title: [Genetic polymorphism of vitamin D receptor and osteoporosis].
abstract: BACKGROUND
  Genetic factors condition an important part of bone mass. The role of vitamin D receptor polymorphism (VDR) as genetic marker of osteoporosis is a matter of discussion. We have studied the possible influence of VDR on bone remodelling, calciotropic hormones, on the presence of osteoporosis and osteoporotic bone fractures. PATIENTS, CONTROL POPULATION AND METHODS: A case-control study. We have studied a total of 127 postmenopausal Canarian women from Canary Islands, Spain; 66 healthy controls and 61 with the diagnosis of osteoporosis, which was made by clinical, radiological and densitometric criteria. 17 osteoporotic women have had a fracture: Colles, hip or vertebral (spinal deformity index) fracture. VDR were determined by PCR directed to demonstrate the presence (b) or absence (B) of a restriction target for Bsml in intron 7. We analyzed some biochemical markers of bone remodelling: serum levels of alkaline phosphatase, tartrate resistant acid phosphatase and urine ratios of calcium/creatinine and hydroxyproline/creatinine. We also determined calciotropic hormones: parathyroid hormone and calcitonin. Bone mass was measured by DEXA and TC.
  
  
  RESULTS
  There were no significant differences in either biochemical bone remodelling markers or in bone mass between the three genotypes: bb, Bb and BB, either in controls or in osteoporotic women with the exception of alkaline phosphatase which had a significative increase compared to control in women with unfavorable alleles distribution (bB and BB). Distribution of genotypes was similar between controls and osteoporotic women, with or without fractures.
  
  
  CONCLUSIONS
  In Canarian women, VDR genotype is not associated with changes in biochemical markers of bone remodelling or in bone mass or with the presence of osteoporosis or osteoporotic fractures.
authors.affiliation: Departamento de Ciencias Clínicas, Universidad de Las Palmas de Gran Canaria.
authors.forename: M
authors.initials: M
authors.lastname: Sosa Henríquez
authors.forename: A
authors.initials: A
authors.lastname: Torres Ramírez
authors.forename: C
authors.initials: C
authors.lastname: Domínguez Cabrera
authors.forename: E
authors.initials: E
authors.lastname: Salido
authors.forename: P
authors.initials: P
authors.lastname: Saavedra Santana
authors.forename: Y
authors.initials: Y
authors.lastname: Barrios
authors.forename: J M
authors.initials: JM
authors.lastname: Limiñana Cañal
authors.forename: P
authors.initials: P
authors.lastname: Betancor León
mesh_terms: D015502:Absorptiometry, Photon; D000328:Adult; D000368:Aged; D016723:Bone Remodeling; D002116:Calcitonin / Q000097:blood; D016022:Case-Control Studies; D003627:Data Interpretation, Statistical; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000175:diagnosis / Q000235:genetics*; D010281:Parathyroid Hormone / Q000097:blood; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018167:Receptors, Calcitriol / Q000235:genetics*
chemical_list: D005819:Genetic Markers; D010281:Parathyroid Hormone; D018167:Receptors, Calcitriol; D002116:Calcitonin
vernacular_title: Polimorfismo genético del receptor de la vitamina D y osteoporosis.